Possible contribution of 8-hydroxydeoxyguanosine to gene mutations in the kidney DNA of gpt delta rats following potassium bromate treatment. 2024

Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.

8-Hydroxydeoxyguanosine (8-OHdG) is well known not only as an effective biomarker of oxidative stress but also as a mutagenic DNA modification. Incorporation of dAMP at the opposite site of 8-OHdG induces G>T or A>C transversions. However, in vivo analyses of gene mutations caused by potassium bromate (KBrO3), which can induce 8-OHdG at carcinogenic target sites, showed that G>T was prominent in the small intestines of mice, but not in the kidneys of rats. Because KBrO3 was a much clearer carcinogen in the kidneys of rats, detailed analyses of gene mutations in the kidney DNA of rats treated with KBrO3 could improve our understanding of oxidative stress-mediated carcinogenesis. In the current study, site-specific reporter gene mutation assays were performed in the kidneys of gpt delta rats treated with KBrO3. Groups of 5 gpt delta rats were treated with KBrO3 at concentrations of 0, 125, 250, or 500 ppm in the drinking water for 9 weeks. At necropsy, the kidneys were macroscopically divided into the cortex and medulla. 8-OHdG levels in DNA extracted from the cortex were dramatically elevated at concentrations of 250 ppm and higher compared with those from the medulla. Cortex-specific increases in mutant frequencies in gpt and red/gam genes were found at 500 ppm. Mutation spectrum and sequence analyses of their mutants demonstrated significant elevations in A>T transversions in the gpt gene and single base deletions at guanine or adenine in the gpt or red/gam genes. While A>T transversions and single base deletions of adenine may result from the oxidized modification of adenine, the contribution of 8-OHdG to gene mutations was limited despite possible participation of the 8-OHdG repair process in guanine deletion.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D001959 Bromates Negative ions or salts derived from bromic acid, HBrO3. Bromate
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006147 Guanine
D000080242 8-Hydroxy-2'-Deoxyguanosine Common oxidized form of deoxyguanosine in which C-8 position of guanine base has a carbonyl group. 2'-Deoxy-7,8-Dihydro-8-Oxoguanosine,2'-Deoxy-8-Hydroxyguanosine,2'-Deoxy-8-Oxo-7,8-Dihydroguanosine,2'-Deoxy-8-Oxoguanosine,7,8-Dihydro-8-Oxo-2'-Deoxyguanosine,7-Hydro-8-Oxodeoxyguanosine,8-Hydroxydeoxyguanosine,8-Oxo-2'-Deoxyguanosine,8-Oxo-7,8-Dihydro-2'-Deoxyguanosine,8-Oxo-7,8-Dihydrodeoxyguanosine,8-Oxo-7-Hydrodeoxyguanosine,8-Oxo-Deoxyguanosine,8OHdG,8-OH-dG,8-oxo-dG,8-oxo-dGuo,8-oxodG,8-oxodGuo,2' Deoxy 7,8 Dihydro 8 Oxoguanosine,2' Deoxy 8 Hydroxyguanosine,2' Deoxy 8 Oxo 7,8 Dihydroguanosine,2' Deoxy 8 Oxoguanosine,7 Hydro 8 Oxodeoxyguanosine,7,8 Dihydro 8 Oxo 2' Deoxyguanosine,8 Hydroxy 2' Deoxyguanosine,8 Hydroxydeoxyguanosine,8 Oxo 2' Deoxyguanosine,8 Oxo 7 Hydrodeoxyguanosine,8 Oxo 7,8 Dihydro 2' Deoxyguanosine,8 Oxo 7,8 Dihydrodeoxyguanosine,8 Oxo Deoxyguanosine
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
December 1987, Carcinogenesis,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
March 2009, Toxicology,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
February 1991, Japanese journal of cancer research : Gann,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
August 1995, Carcinogenesis,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
November 2013, Amino acids,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
May 1989, Cancer research,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
January 2020, Mutation research. Genetic toxicology and environmental mutagenesis,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
May 1994, Toxicology and applied pharmacology,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
January 1999, Environmental and molecular mutagenesis,
Ken Kuroda, and Yuji Ishii, and Shinji Takasu, and Aki Kijima, and Kohei Matsushita, and Ken-Ichi Masumura, and Takehiko Nohmi, and Takashi Umemura
December 1993, Carcinogenesis,
Copied contents to your clipboard!